Proteostasis impairment and ALS.

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by motor neuron loss.
• Current treatments for ALS are ineffective, highlighting the need for novel therapeutic targets.
• Growing evidence links impaired proteostasis to the pathogenesis of ALS.

Purpose of the Study:

• To review and synthesize existing literature on the role of proteostasis in ALS.
• To explore how genetic mutations in ALS disrupt proteostasis.
• To propose proteostasis as a therapeutic target for ALS.

Main Methods:

• Literature review and synthesis.
• Analysis of genetic mutations associated with ALS.
• Examination of mRNA metabolism and protein degradation pathways in ALS.

Main Results:

• Genetic mutations in ALS destabilize the proteome, leading to proteostasis imbalance.
• Defects in mRNA metabolism and protein degradation converge on proteostasis dysfunction.
• The metastable nature of the proteome makes it vulnerable in ALS.

Conclusions:

• Proteostasis dysfunction is a key mechanism underlying motor neuron death in ALS.
• The proteostasis network represents a potential therapeutic target for ALS treatment.
• Further research into proteostasis mechanisms could lead to effective ALS therapies.